Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety and antibody response to the first dose of severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine in persons with HIV
Jake A. Ruddy, Brian J. Boyarsky, William A. Werbel, et al.
AIDS (2021) Vol. 35, Iss. 11, pp. 1872-1874
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial
Peter Bergman, Ola Blennow, Lotta Hansson, et al.
EBioMedicine (2021) Vol. 74, pp. 103705-103705
Open Access | Times Cited: 202
The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living With Human Immunodeficiency Virus (HIV)
Bezawit A. Woldemeskel, Andrew H. Karaba, Caroline C. Garliss, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 7, pp. 1268-1270
Open Access | Times Cited: 136
Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy
Zabrina L. Brumme, Francis Mwimanzi, Hope R. Lapointe, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 84
Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV
Jake A. Ruddy, Brian J. Boyarsky, Justin R. Bailey, et al.
AIDS (2021) Vol. 35, Iss. 14, pp. 2399-2401
Open Access | Times Cited: 71
Evaluation of Humoral and Cellular Responses in SARS-CoV-2 mRNA Vaccinated Immunocompromised Patients
Matthijs Oyaert, Marie‐Angélique De Scheerder, Sophie Van Herrewege, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 53
Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study
Lucas Chaves Netto, Karim Yaqub Ibrahim, Camila de Melo Picone, et al.
The Lancet HIV (2022) Vol. 9, Iss. 5, pp. e323-e331
Open Access | Times Cited: 48
The immune response to SARS-CoV-2 in people with HIV
Maxine A. Höft, Wendy A. Burgers, Catherine Riou
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 184-196
Open Access | Times Cited: 32
Humoral immune response following prime and boost BNT162b2 vaccination in people living with HIV on antiretroviral therapy
Nils Jedicke, Metodi V. Stankov, Anne Cossmann, et al.
HIV Medicine (2021) Vol. 23, Iss. 5, pp. 558-563
Open Access | Times Cited: 54
Severe immunosuppression is related to poorer immunogenicity to SARS-CoV-2 vaccines among people living with HIV
Anaïs Corma‐Gómez, Marta Fernández‐Fuertes, Estefania García, et al.
Clinical Microbiology and Infection (2022) Vol. 28, Iss. 11, pp. 1492-1498
Open Access | Times Cited: 31
Impact on HIV-1 RNA Levels and Antibody Responses Following SARS-CoV-2 Vaccination in HIV-Infected Individuals
Vera Portillo, Chiara Fedeli, Pilar Ustero, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 30
High seroconversion rate after vaccination with mRNA BNT162b2 vaccine against SARS-CoV-2 among people with HIV – but HIV viremia matters?
Xinling Xu, Jan Vesterbacka, Soo Aleman, et al.
AIDS (2022) Vol. 36, Iss. 3, pp. 479-481
Closed Access | Times Cited: 29
Immunogenicity, effectiveness and safety of SARS-CoV-2 vaccination in people living with HIV: A systematic review and meta-analysis
David Griffin, Rekha Pai Mangalore, Jennifer Hoy, et al.
AIDS (2023)
Open Access | Times Cited: 16
Safety and Immunogenicity of SARS-CoV-2 vaccines in people with HIV
Manuel González de Aledo, Angelina Cañizares, Pilar Vázquez‐Rodríguez, et al.
AIDS (2022) Vol. 36, Iss. 5, pp. 691-695
Open Access | Times Cited: 26
Immune response and safety to inactivated COVID-19 vaccine: a comparison between people living with HIV and HIV-naive individuals
Shi Zou, Mengmeng Wu, Fangzhao Ming, et al.
AIDS Research and Therapy (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 25
Immunogenicity of COVID-19 vaccines and their effect on HIV reservoir in older people with HIV
Vitaliy Matveev, Erik Z. Mihelic, Erika Benko, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107915-107915
Open Access | Times Cited: 15
Correlation between CD4 T-Cell Counts and Seroconversion among COVID-19 Vaccinated Patients with HIV: A Meta-Analysis
Qian Zhou, Yihuang Liu, Furong Zeng, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 789-789
Open Access | Times Cited: 14
Qualitative assessment of anti‐SARS‐CoV‐2 spike protein immunogenicity (QUASI) after COVID‐19 vaccination in older people living with HIV
Jessica Tuan, Heidi Zapata, Terese Critch‐Gilfillan, et al.
HIV Medicine (2021) Vol. 23, Iss. 2, pp. 178-185
Open Access | Times Cited: 30
Six-month immune responses to mRNA-1273 Vaccine in cART-treated late presenter people living with HIV according to previous SARS-CoV-2 Infection
Matteo Augello, Valeria Bono, Roberta Rovito, et al.
AIDS (2023) Vol. 37, Iss. 10, pp. 1503-1517
Open Access | Times Cited: 11
A Systematic Review of COVID-19 Vaccine Antibody Responses in People With HIV
Helen Chun, Kyle Milligan, Elfriede Agyemang, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 11
Open Access | Times Cited: 17
Serological response following COVID-19 vaccines in patients living with HIV: a dose–response meta-analysis
Qian Zhou, Furong Zeng, Yu Meng, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
mRNA- and Adenovirus-Based Vaccines against SARS-CoV-2 in HIV-Positive People
Anna Rosa Garbuglia, Claudia Minosse, Paola Del Porto
Viruses (2022) Vol. 14, Iss. 4, pp. 748-748
Open Access | Times Cited: 15
Impact of Chronic HIV Infection on SARS-CoV-2 Infection, COVID-19 Disease and Vaccines
Yexin Yang, Akiko Iwasaki
Current HIV/AIDS Reports (2021) Vol. 19, Iss. 1, pp. 5-16
Open Access | Times Cited: 18
Anti-SARS-COV-2 specific immunity in HIV immunological non-responders after mRNA-based COVID-19 vaccination
Marta Sisteré‐Oró, Naína Andrade, Diana D. J. Wortmann, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Humoral immune response to inactivated COVID-19 vaccination at the 3rd month among people living with HIV
Songjie Wu, Shi Zou, Fangzhao Ming, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
The safety and immunogenicity of a two-dose schedule of CoronaVac, and the immune persistence of vaccination for six months, in people living with HIV: A multicenter prospective cohort study
Yuxiao Wang, Ying Qiao, Yuqi Huo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top